NCT05621915View on ClinicalTrials.gov

Nadroparin Pharmacokinetics in Different Stages of COVID-19

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

February 10, 2022

Study Completion Date

April 15, 2022

Conditions
ThrombosisNadroparinCOVID-19Mechanical VentilationAnticoagulants and Bleeding Disorders
Interventions
DRUG

Nadroparin

Subcutaneous injection of nadroparin according to the ICU guidelines for thromboprophylaxis in ICU patients.

Trial Locations (1)

20-059

2nd Department of Anesthesiology and Critical Care, Medical University of Lublin, Lublin

All Listed Sponsors
collaborator

Medical University of Gdansk

OTHER

lead

Medical University of Lublin

OTHER

NCT05621915 - Nadroparin Pharmacokinetics in Different Stages of COVID-19 | Biotech Hunter | Biotech Hunter